The bill amends section 766.101 of the Florida Statutes, which pertains to medical malpractice review committees. It revises the definition of a medical review committee to include additional entities, specifically a managing entity as defined in s. 394.9082(2), and clarifies the roles of various committees involved in health care quality assurance. The bill also updates the language regarding the immunity from liability for these committees, ensuring that their investigations, proceedings, and records are not subject to discovery or admissible as evidence in civil or administrative actions against health care providers or managing entities.

Key changes include the removal of certain phrases that previously indicated approval by governing boards for quality assurance programs and the introduction of new language that broadens the scope of entities involved in peer review and utilization review processes. The bill emphasizes that while the proceedings of these committees are protected from discovery, information from original sources remains accessible, and individuals can testify about their knowledge outside of the committee context. The act is set to take effect on July 1, 2025.